MUC16 and neoplasm: Zou et al. (2022) analysed routine tests indicators: neutrophil-to-lymphocyte ratio (NLR), red cell distribution width (RDW) and serum tumour markers (CEA, CA15-3, CA125, CA19-9) in BC and breast fibroadenoma (FA).